Diabetes Insulin Delivery Pen market – Industry Trends and Forecast to 2028

Global Diabetes Insulin Delivery Pen Market Overview

The global diabetes insulin delivery pen market size is estimated at 31.8 USD Billion with a CAGR of 4.7% during the forecasted period from 2021-2028. Diabetic patients make use of an insulin pen to control insulin. It is a convenient way of taking insulin doses through an injection. It eliminates the necessity to hold the syringe and vial, and thus the patients can control the insulin in their workplace or wherever required.

The growth of the market is driven by strong government support in selected countries, the satisfactory reimbursement scenario and technical advancements in insulin delivery devices are driving the demand for the market growth in the forthcoming period. In addition, rising awareness about insulin delivery devices, and growing diabetic populace are also propelling the market growth.

On the other hand, the oral insulin as an alternative drug delivery method, and needle anxiety in patients are likely to affect the market growth in the forecast period.

Global Diabetes Insulin Delivery Pens Market is valued at USD 3868.4 Million in 2018 and expected to reach USD 6847.6 Million by 2025 with the CAGR of 8.50% over the forecast period.

The Global Diabetes Insulin Delivery Pen Market report is a precise and deep-dive study on the current state that aims at the major drivers, market strategies, and imposing growth of the key players. Worldwide Diabetes Insulin Delivery Pen Industry also offers a granular study of the dynamics, segmentation, revenue, share forecasts, and allows you to make superior business decisions. The report serves imperative statistics on the market stature of the prominent manufacturers and is an important source of guidance and advice for companies and individuals involved in the Diabetes Insulin Delivery Pen industry.

Impact of Coronavirus (COVID-19) on Global Diabetes Insulin Delivery Pen Market.

Coronavirus (COVID-19) is spreading across the world with a serious impact on the economy and the global market. The report considers and accounts for the impact of COVID-19 on Global Diabetes Insulin Delivery Pen Market across all the segments, regions, countries, and key players. North America and Europe are worst-hit countries by Coronavirus which are key players in the global economy. The report provides a detailed analysis of the impact on the market, growth strategies, supply china disruption, consumption pattern of the Global Diabetes Insulin Delivery Pen Market.

Market Segmentation

The report provides market size with 2019 as the base year in consideration and a yearly forecast until 2030 in terms of Revenue (USD Million). The estimates for all segments including type and application have been provided on a regional basis for the forecast period mentioned above. We have implemented a mix of top-down and bottom-up approaches for market sizing, analyzing the key regional markets, dynamics, and trends for various applications.

The Global Diabetes Insulin Delivery Pen Market has been estimated by integrating the regional markets.

Global Diabetes Insulin Delivery Pen Market by Key Segments:

By Type:

• Reusable Insulin Pens
• Disposable Insulin Pens

By Application:

• Hospital & Clinic
• Retail Pharmacy
• Online Sales

By End-User:

• Hospitals & Clinics
• Ambulatory Surgical Centers
• Home Care Settings

Competitive Landscape:

Key players profile in the report include

• Sanofi
• Eli Lilly
• Bigfoot Biomedical
• Medtronic
• Novo Nordisk
• Insulet Corporation
• Becton
• Dickinson and Company (BD)
• Roche
• Ypsomed
• Wockhardt
• B. Braun

The report of Global Diabetes Insulin Delivery Pen Market studies the key players present in the market. The chapter includes the competitive landscape section which provides the full and in-depth analysis of the current market trends, changing technologies, and developments that will be beneficial for the companies, which are competing in the market. The report offers an overview of revenue, demand, and supply of data, futuristic cost, and growth analysis during the projected year. In addition to a brief overview of the company, analysts shed light on their valuation and evolution. It also discusses the list of important products and the ones in the pipeline. The competitive landscape is analyzed by understanding the approaches of the companies and the initiatives they have taken in recent years to triumph over the intensive competition.

Regional Analysis

By Geography

• North America
  • U.S.
  • Canada
• Europe
  • U.K
  • Germany
  • France
  • Italy
  • Rest of Europe
• Asia Pacific
  • India
  • China
  • Japan
  • South Korea
  • Rest of Asia Pacific
• South America
  • Brazil
  • Argentina
  • Mexico
  • Rest of South America
• Middle East & Africa
  • GCC Countries
  • Africa
  • Rest of Middle East

Frequently Asked Questions (FAQ):

• What is the size of the Global Diabetes Insulin Delivery Pen Market?
• How much will this market be worth from 2020 to 2030?
• What are the major deals happenings in the Global Diabetes Insulin Delivery Pen Market?
• Which country is expected to hold the highest market share in the Global Diabetes Insulin Delivery Pen Market?
• What are production processes, major issues, and solutions to mitigate the development risk?
• Who are the top players and what are their activities, revenue, recent developments, and prospects?
• What are the main drivers and restraints in the Global Diabetes Insulin Delivery Pen Market?
• Which are the largest revenue generating products, services or regions and their comparative growth rate?

Table of Contents

1 Market Overview
1.1 Diabetes Insulin Delivery Pens Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Diabetes Insulin Delivery Pens Revenue by Type: 2015 VS 2019 VS 2030
1.2.2 Reusable Insulin Pens
1.2.3 Disposable Insulin Pens
1.3 Market Analysis by Application
1.3.1 Overview: Global Diabetes Insulin Delivery Pens Revenue by Application: 2015 VS 2019 VS 2030
1.3.2 Hospital & Clinic
1.3.3 Retail Pharmacy
1.3.4 Online Sales
1.4 Overview of Global Diabetes Insulin Delivery Pens Market
1.4.1 Global Diabetes Insulin Delivery Pens Market Status and Outlook (2015-2030)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Novo Nordisk
2.1.1 Novo Nordisk Details
2.1.2 Novo Nordisk Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Novo Nordisk SWOT Analysis
2.1.4 Novo Nordisk Product and Services
2.1.5 Novo Nordisk Diabetes Insulin Delivery Pens Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Ganlee
2.2.1 Ganlee Details
2.2.2 Ganlee Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Ganlee SWOT Analysis
2.2.4 Ganlee Product and Services
2.2.5 Ganlee Diabetes Insulin Delivery Pens Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 BD
2.3.1 BD Details
2.3.2 BD Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BD SWOT Analysis
2.3.4 BD Product and Services
2.3.5 BD Diabetes Insulin Delivery Pens Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Eli Lilly
2.4.1 Eli Lilly Details
2.4.2 Eli Lilly Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Eli Lilly SWOT Analysis
2.4.4 Eli Lilly Product and Services
2.4.5 Eli Lilly Diabetes Insulin Delivery Pens Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Owen Mumford
2.5.1 Owen Mumford Details
2.5.2 Owen Mumford Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Owen Mumford SWOT Analysis
2.5.4 Owen Mumford Product and Services
2.5.5 Owen Mumford Diabetes Insulin Delivery Pens Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Sanofi
2.6.1 Sanofi Details
2.6.2 Sanofi Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Sanofi SWOT Analysis
2.6.4 Sanofi Product and Services
2.6.5 Sanofi Diabetes Insulin Delivery Pens Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Dongbao
2.7.1 Dongbao Details
2.7.2 Dongbao Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Dongbao SWOT Analysis
2.7.4 Dongbao Product and Services
2.7.5 Dongbao Diabetes Insulin Delivery Pens Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Ypsomed Holding
2.8.1 Ypsomed Holding Details
2.8.2 Ypsomed Holding Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Ypsomed Holding SWOT Analysis
2.8.4 Ypsomed Holding Product and Services
2.8.5 Ypsomed Holding Diabetes Insulin Delivery Pens Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Delfu
2.9.1 Delfu Details
2.9.2 Delfu Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Delfu SWOT Analysis
2.9.4 Delfu Product and Services
2.9.5 Delfu Diabetes Insulin Delivery Pens Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Diabetes Insulin Delivery Pens Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Diabetes Insulin Delivery Pens Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Diabetes Insulin Delivery Pens Manufacturer Market Share in 2019
3.3.2 Top 6 Diabetes Insulin Delivery Pens Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Diabetes Insulin Delivery Pens Sales, Revenue and Market Share by Regions
4.1.1 Global Diabetes Insulin Delivery Pens Sales and Market Share by Regions (2015-2030)
4.1.2 Global Diabetes Insulin Delivery Pens Revenue and Market Share by Regions (2015-2030)
4.2 North America Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
4.3 Europe Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
4.4 Asia-Pacific Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
4.5 South America Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
4.6 Middle East and Africa Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
5 North America by Country
5.1 North America Diabetes Insulin Delivery Pens Sales, Revenue and Market Share by Country
5.1.1 North America Diabetes Insulin Delivery Pens Sales and Market Share by Country (2015-2030)
5.1.2 North America Diabetes Insulin Delivery Pens Revenue and Market Share by Country (2015-2030)
5.2 United States Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
5.3 Canada Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
5.4 Mexico Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
6 Europe by Country
6.1 Europe Diabetes Insulin Delivery Pens Sales, Revenue and Market Share by Country
6.1.1 Europe Diabetes Insulin Delivery Pens Sales and Market Share by Country (2015-2030)
6.1.2 Europe Diabetes Insulin Delivery Pens Revenue and Market Share by Country (2015-2030)
6.2 Germany Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
6.3 UK Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
6.4 France Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
6.5 Russia Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
6.6 Italy Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Diabetes Insulin Delivery Pens Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Diabetes Insulin Delivery Pens Sales and Market Share by Regions (2015-2030)
7.1.2 Asia-Pacific Diabetes Insulin Delivery Pens Revenue and Market Share by Regions (2015-2030)
7.2 China Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
7.3 Japan Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
7.4 Korea Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
7.5 India Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
7.6 Southeast Asia Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
7.7 Australia Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
8 South America by Country
8.1 South America Diabetes Insulin Delivery Pens Sales, Revenue and Market Share by Country
8.1.1 South America Diabetes Insulin Delivery Pens Sales and Market Share by Country (2015-2030)
8.1.2 South America Diabetes Insulin Delivery Pens Revenue and Market Share by Country (2015-2030)
8.2 Brazil Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
8.3 Argentina Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Diabetes Insulin Delivery Pens Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Diabetes Insulin Delivery Pens Sales and Market Share by Country (2015-2030)
9.1.2 Middle East & Africa Diabetes Insulin Delivery Pens Revenue and Market Share by Country (2015-2030)
9.2 Saudi Arabia Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
9.3 Turkey Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
9.4 Egypt Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
9.5 South Africa Diabetes Insulin Delivery Pens Sales and Growth Rate (2015-2030)
10 Market Segment by Type
10.1 Global Diabetes Insulin Delivery Pens Sales and Market Share by Type (2015-2030)
10.2 Global Diabetes Insulin Delivery Pens Revenue and Market Share by Type (2015-2030)
10.3 Global Diabetes Insulin Delivery Pens Price by Type (2015-2030)
11 Global Diabetes Insulin Delivery Pens Market Segment by Application
11.1 Global Diabetes Insulin Delivery Pens Sales Market Share by Application (2015-2030)
11.2 Global Diabetes Insulin Delivery Pens Revenue Market Share by Application (2015-2030)
11.3 Global Diabetes Insulin Delivery Pens Price by Application (2015-2030)
12 Market Forecast
12.1 Global Diabetes Insulin Delivery Pens Sales, Revenue and Growth Rate (2021-2030)
12.2 Diabetes Insulin Delivery Pens Market Forecast by Regions (2021-2030)
12.2.1 North America Diabetes Insulin Delivery Pens Market Forecast (2021-2030)
12.2.2 Europe Diabetes Insulin Delivery Pens Market Forecast (2021-2030)
12.2.3 Asia-Pacific Diabetes Insulin Delivery Pens Market Forecast (2021-2030)
12.2.4 South America Diabetes Insulin Delivery Pens Market Forecast (2021-2030)
12.2.5 Middle East & Africa Diabetes Insulin Delivery Pens Market Forecast (2021-2030)
12.3 Diabetes Insulin Delivery Pens Market Forecast by Type (2021-2030)
12.3.1 Global Diabetes Insulin Delivery Pens Sales Forecast by Type (2021-2030)
12.3.2 Global Diabetes Insulin Delivery Pens Market Share Forecast by Type (2021-2030)
12.4 Diabetes Insulin Delivery Pens Market Forecast by Application (2021-2030)
12.4.1 Global Diabetes Insulin Delivery Pens Sales Forecast by Application (2021-2030)
12.4.2 Global Diabetes Insulin Delivery Pens Market Share Forecast by Application (2021-2030)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

Key players profile in the report include

• Sanofi
• Eli Lilly
• Bigfoot Biomedical
• Medtronic
• Novo Nordisk
• Insulet Corporation
• Becton
• Dickinson and Company (BD)
• Roche
• Ypsomed
• Wockhardt
• B. Braun